Methionine-Restricted Diet Increases miRNAs That Can Target RUNX2 Expression and Alters Bone Structure in Young Mice

Jason Plummer1, Miri Park1, Frantz Perodin1

  • 1Orentreich Foundation for the Advancement of Science, Inc., Cold Spring, New York.

Insights

Dietary methionine restriction (MR) in young mice negatively impacts bone structure and strength. This longevity intervention increases specific microRNAs (miRNAs) that may inhibit bone formation, leading to more fragile bones.

Area of Science:

  • Bone Biology
  • Metabolic Regulation
  • Aging Research

Background:

  • Dietary methionine restriction (MR) is known to extend lifespan and improve healthspan in rodent models.
  • Understanding the systemic effects of MR on various tissues, including bone, is crucial for evaluating its therapeutic potential.

Purpose of the Study:

  • To investigate the impact of dietary methionine restriction on bone structure, formation, and remodeling in young male mice.
  • To identify potential molecular mechanisms, including microRNA regulation, underlying MR-induced bone alterations.

Main Methods:

  • Young male C57BL/6J mice were subjected to dietary methionine restriction (0.12% methionine) or control diet (0.86% methionine) for 5 weeks.
  • Analyses included plasma biomarker assessment, bone histomorphometry, micro-computed tomography (micro-CT), biomechanical testing, and gene/microRNA expression profiling.

Main Results:

  • Methionine restriction led to reduced plasma glucose and insulin, with increased FGF21 and FGF23.
  • Bone analysis revealed decreased cortical and trabecular bone tissue density, reduced bone volume, and impaired biomechanical properties, indicating increased fragility.
  • Elevated levels of specific microRNAs (e.g., miR-31, miR-133a) were observed in plasma, liver, and bone marrow, potentially targeting RUNX2 and Osterix, key regulators of osteoblast differentiation.

Conclusions:

  • Dietary methionine restriction in young animals significantly alters bone structure and biomechanical properties, leading to increased bone fragility.
  • The observed changes in bone are associated with altered metabolic markers and an increase in specific microRNAs in bone and liver, suggesting a novel regulatory pathway impacting bone formation.